CRISPR THERAPEUTICS AG COM CHF0.03 earnings per share and revenue

0VRQ earnings per share for the last quarter are -1.01 USD whereas the estimation was -1.38 USD which accounts for 27.06% surprise. Company revenue for the same period amounts to 602.00 k USD despite the estimated figure of 6.57 M USD. Estimated earnings per share for the next quarter are -1.25 USD, and revenue is expected to reach 7.90 M USD. Also watch annual changes over time to get a bigger picture of 0VRQ earnings per share and revenue dynamics.